about us | newsletter | contact | archive | members area
Randy Tharp, Epstein Architecture & Engineering
The tax agents try to get more taxes out of the legitimate companies, but almost complet»
  News:      POLITICS   |   ECONOMICS   |   ENERGY   |   INVESTMENTS   |   APPOINTMENTS   |   GREEN   |   INFRASTRUCTURE   |   REAL ESTATE   |   AGRIBUSINESS   |   DRIVING   |   CITY LIFE   |   EVENTS   |

Cegedim: Pharmaceutical segment in Romania loses 4 per cent in Q1 and reaches 669 million Euro

The pharmaceutical products sales in Romania, reflected in the distribution price decreased by four per cent in Q1 this year compared to the same interval of 2013 and reached a total value of 668.8 million Euro, under expectations, according to Cegedim data.

2014-05-20 10:54:21

Petru Craciun, general manager of Cegedim states that the slightly warmer winter is accountable for the results. For 2014, in the context of a yet not updated subsidized medicine product list, the estimates take into account a decrease from 2.7 per cent to -0.3 per cent in local currency for the market. The decrease in lei for the Q1 was estimated at 1.5 per cent, to 3 billion lei.

In Q1, the pharmaceutical retail segment for Rx products reached 471.7 million Euro (2.12 billion lei), 2.2 per cent less while OTCs accounted for 109 million Euro (490 million lei), increased value of 2.4 per cent. The overall retail decreased in Q1 with 3.9 per cent and reached 580.6 million Euro, while other distribution channels such as hospitals increased with 4.9 per cent to 88.2 million Euro.

The company ranking for this market is led by Servier with 673.3 million lei and increase of 5.8 per cent, Pfizer with 600.1 million lei and 5.1 per cent increase, GlaxoSmithKline (510,3 million lei and 4,4 per cent), Ranbaxy (464,6 million lei and 4 per cent), Merck&Co (450,5 million lei and 3,8 per cent), AstraZeneca (440,3 million lei and 3,8 per cent) and Krka (316 million lei and 2,7 per cent).

They are followed by Johnson&Johnson, Antibiotice, Abbvie, Teva, Menarini, Bayer, Bristol Myers Squibb, Alvogen, Actavis and Eli Lilly, with market shares between 2.5 per cent and 1.6 per cent.



COMMENTS
There are 0 comments:

 
ADD A COMMENT
 
Name
Email
Comment
Validation Code
   
 
 

0 Comments  |  1655 Views
Daily Info
Huawei plans EUR 130mln turnover in Romania this year

Huawei Technologies Romania aims to post EUR 130 million turnover this year, a slight growth over 2013, when the company registered EUR 127 million.

Rudolf Lukavsky: Companies from Austria invest 10.9 billion Euro in Romania

Austrian companies investments in Romania total 10.9 billion Euro and represent 18.5 per cent of the total foreign direct investments made in Romania, Rudolf Lukavsky, commer...

PwC: Infrastructure expenses will grow by 5 per cent until 2025

Expenses with infrastructure in Romania will grow by 5% until 2025, more rapidly than in Western Europe, but slower than at global level, the total amount allocated reaching 3...

Business owners and antreprenors, diplomats and international analists participate at Forbes CEE Forum 2014

Forbes CEE Forum organized by Forbes Romania during 23 and 24 September 2014 brings together regional leaders to discuss strategic economic directions for Central and East...

Wolfgang Schulz is the new GM of BMW Group Romania

Starting October, Wolfgang Schulz, 47, currently the head of key account corporate sales at BMW Group Germania will take over the responsabilities as general manager for BM...

 
 
   
advertising

advertising

advertising

advertising

advertising

advertising

advertising

More on News
Klaus Iohannis is Liberals' choice for presidency

The liberal head Klaus Iohannis has been elected the party′s candidate for the presidential elections to be held in November in Romania, as announced by the former leader...

Operational Leasing market to register double-digit growth in H1

The Operational leasing market recorded an increase of 12.3 per cent at the end of Q2 over the same period last year, reaching 45,000 units. Moreover, the market is expecte...

ExxonMobil and OMV Petrom to start drilling in the Black Sea

In early July, the American- based company ExxonMobil Exploration and Production in Romania and OMV Petrom, part of the Austrian OMV Petrom group, jointly announced the beg...

A contract over 18 million Euro for building a part of Brasov ring road has been assigned

Romanian National Company of Motorways and National Roads (CNADNR) assigned a contract worth 18 million Euro (80 million RON) for the construction of 4.9 km of Brasov's rin...

Perry Zizzi

Perry Zizzi, with 19 years of experience practicing law in the US, Latin America, Western Europe and the emerging markets of Central and Eastern Europe rejoined law firm De...

Eco-Rom Ambalaje recycled 2.6 million tonnes of packaging waste in the past decade

Eco-Rom Ambalaje, one of the most important organizations specialised in the assumption of packaging recycling and recovery obligations from economic agents, recycled aroun...

Romanian farmers need to integrate further within the value chain

Given the fact that in the coming 20 years the global demand for food will grow by 70 per cent, Romania can play an important role in providing the necessary supply, Reinde...